Trial Profile
Planned phase I/II trial of HSV 1716 in patients with hepatocellular carcinoma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 28 Aug 2013
Price :
$35
*
At a glance
- Drugs HSV 1716 (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2013 New trial record